Insider · CIK 0001664386
Pankaj Mohan
Files at SONN (Sonnet BioTherapeutics Holdings, Inc.). First filing -, latest -.
Pankaj Mohan files SEC Form 4 as CEO, president, chair and director at SONN (Sonnet BioTherapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Pankaj Mohan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +7,554 | - | - | 14,987 | Dec 5, 2024 |
Questions about Pankaj Mohan
Answered from the filings on this page, as of the latest one.
Is Pankaj Mohan buying or selling?
Pankaj Mohan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Pankaj Mohan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pankaj Mohan has 0.
Where does Pankaj Mohan file Form 4?
Pankaj Mohan has filed Form 4 at SONN (Sonnet BioTherapeutics Holdings, Inc.) as Chairman, President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.